{"id":"W2234278652","doi":"10.1185/03007995.2016.1140030","title":"Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Hazard ratio; Internal medicine; Myeloid leukemia; Imatinib; Medicare Advantage; Medicare Part D; Emergency medicine; Health care; Medical prescription; Confidence interval; Pharmacology; Prescription drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008528278,0.0003958347,0.0005855384,0.0003635061,0.0002609298,0.00009957548,0.0001178662,0.0003087725,0.0004783371],"category_scores_gemma":[0.0005562542,0.0002357334,0.00005332437,0.000283253,0.0004190582,0.0002904418,0.0001277309,0.0006610479,0.000006389634],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005059759,"about_ca_system_score_gemma":0.003620271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002848865,"about_ca_topic_score_gemma":0.01162271,"domain_scores_codex":[0.9955936,0.000474913,0.0005492312,0.0008556472,0.001653641,0.0008729681],"domain_scores_gemma":[0.9973548,0.0007221737,0.0001147827,0.0004409588,0.0002619335,0.001105357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001951517,0.000504595,0.1172723,0.0005502699,0.0001191651,0.000249487,0.0005517734,0.000001246438,0.003392319,0.0002473409,0.00075037,0.8744096],"study_design_scores_gemma":[0.1683556,0.07375668,0.349882,0.04308194,0.0001325314,0.001191066,0.001287301,0.006733107,0.04103938,0.0002843175,0.3118071,0.002448935],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633861,0.03041621,0.00003865343,0.004479703,0.0003055104,0.001196438,0.0001242272,0.00003953317,0.00001363148],"genre_scores_gemma":[0.9496242,0.04829278,0.00002777643,0.00009486145,0.00109937,0.0001130097,0.0005707132,0.00005088411,0.0001263675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8719607,"threshold_uncertainty_score":0.9987596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.113889797740799,"score_gpt":0.3880523490510253,"score_spread":0.2741625513102264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}